MAPK3 and Huntington disease: To confirm the role of ERK1/2 signaling in modulating striatal neurodegeneration in a human model of HD, we took advantage of an induced pluripotent stem cell (IPSCs) line differentiated into SPNs (Figs 5E and F, and EV4D and E).